Milestone B definition

Milestone B shall have the meaning set forth in Exhibit D to the Agreement.
Milestone B means the achievement of $[***] million of Net Revenue for any Eligible Calendar Year for such Milestone. “Milestone C” means the achievement of $[***] million of Net Revenue for any Eligible Calendar Year for such Milestone. “Milestone D” means the achievement of $[***] million of Net Revenue for any Eligible Calendar Year for such Milestone. “Milestone E” means the achievement of $[***] million of Net Revenue for any Eligible Calendar Year for such Milestone. “Milestone F” means the achievement of $250.0 million of Net Revenue for any Eligible Calendar Year for such Milestone. “Milestones” means Milestone A, Milestone B, Milestone C, Milestone D, Milestone E and Milestone F. “Net Revenue” means the gross amounts invoiced for sales by or on behalf of Buyer and its Affiliates and its and their licensees and sublicensees (each such Person, a “Selling Person”) for sales of the Product to third parties in bona fide, arm’s length transactions, less the following to the extent actually incurred, allowed, paid, accrued, specifically allocated, or included in the gross amounts invoiced with respect to such sales to third parties and not otherwise received, recovered by or reimbursed to any Selling Person: *** Pursuant to 17 CFR 240.24b-2, confidential information has been omitted in places marked “[***]” and has been filed separately with the Securities and Exchange Commission pursuant to a Confidential Treatment Application filed with the Commission.
Milestone B has the meaning set out in Section 3.6.

Examples of Milestone B in a sentence

  • The cost reductions from employing the granted and proposed acquisition authorities will be further evaluated to support the Navy’s updated OR Milestone B cost estimate in August 2016....

  • The Navy’s initial cost analysis aligns with CBO’s projections, and the cost reductions from employing these acquisition authorities will be further evaluated to support the Navy’s updated OR Milestone B cost estimate in August 2016....The Under Secretary of Defense for Acquisition, Technology and Logistics (USD AT&L) approved the OR Program Acquisition Strategy on January 4, 2016.

  • Relative to Milestone A, these estimates have been updated to adjust Base Year from 2010 to 2017, a standard practice to match Base Year with the year of Milestone B approval.

  • From Milestone B forward, the affordability cap for the unit cost will be measured by using the Average Procurement Unit Cost (APUC), which includes all 12 hulls.

  • The Association may permit use of Common Area facilities by persons other than Owners and occupants of Units and may charge use fees, in such amount as the Board may establish, for such use.

  • Milestone B approval, which permits a program to enter the engineering and manufacturing development (EMD) phase, is generally considered a major milestone for a defense acquisition program, permitting the program to transition, in effect, from a research and development effort into a procurement program of record.

  • Milestone B also establishes the Acquisition Program Baseline against which the program’s performance will be assessed.

  • A January 6, 2017, Navy notification to Congress on theMilestone B approval for the Columbia-class program states the following:On 4 November 2016, Under Secretary of Defense for Acquisition, Technology and Logistics Frank Kendall chaired the Milestone B Defense Acquisition Board, and on 4 January, 2017 signed the acquisition decision memorandum approving COLUMBIA Class program’s Milestone B and designating the program as an Acquisition Category ID major defense acquisition program.

  • The provision again effectively requires the participation of at least one additional shipyard in the program but does not specify the share of the program that is to go to the additional shipyard.On November 23, 2005, the USD AT&L granted Milestone B approval for the DDG-1000, permitting the program to enter the System Development and Demonstration (SDD) phase.

  • On November 23, 2005, the USD AT&L granted Milestone B approval for the DDG-1000, permitting the program to enter the System Development and Demonstration (SDD) phase.


More Definitions of Milestone B

Milestone B means an operational milestone of the Covenant Parties mutually agreed to by Borrower and the Lenders.
Milestone B means the achievement of $[***] million of Net Revenue for any Eligible Calendar Year for such Milestone.
Milestone B means Borrower has obtained positive Phase 2b data in Topsalysin trial for the treatment of localized prostate cancer prior to December 31, 2018, which shall be confirmed by discussion with Borrower’s management team and a member of Borrower’s Board of Directors that Borrower will advance the development of Topsalysin for the treatment of localized prostate cancer to the next stage.

Related to Milestone B

  • Milestone 2 means achievement of annual Net Sales of at least $35,000,000 during any Calendar Year ending on or before December 31, 2024.

  • Milestone 1 means achievement of annual Net Sales of at least $20,000,000 during the Calendar Year ending on December 31, 2021.

  • Milestone means an event or task described in the Implementation Plan which must be completed by the corresponding date set out in such plan;

  • Development Milestone Payment shall have the meaning set forth in Section 9.2(a).

  • Milestone Date means the date set against the relevant Milestone in the Implementation Plan;

  • Milestone Payment means a payment identified in the Implementation Plan to be made following the issue of a Satisfaction Certificate in respect of Achievement of the relevant Milestone;

  • Milestone Event has the meaning set forth in Section 8.4.

  • Sales Milestone Payment shall have the meaning set forth in Section 8.4.

  • Milestone Events has the meaning set forth in Section 3.3 (Milestone Payments).

  • Development Milestone Event shall have the meaning set forth in Section 9.2(a).

  • Milestone Dates means the dates for completion of specified Project activities as contained in the Project Schedule.

  • Milestones means control points in the project that help to chart progress. Milestones may correspond to the completion of a key deliverable, allowing the next phase of the work to begin. They may also be needed at intermediary points so that, if problems have arisen, corrective measures can be taken. A milestone may be a critical decision point in the project where, for example, the consortium must decide which of several technologies to adopt for further development.

  • Performance Milestone means an act or event specified in section 5.1 and described in section 9 of the EPLA.

  • Milestone Payments has the meaning set forth in Section 4.2.

  • Milestone Schedule means Seller’s milestone schedule, the form of which is attached to this Agreement as Exhibit Q.

  • Project Milestone means the project milestone set forth in Schedule-J;

  • Milestone Payment Date has the meaning set forth in Section 2.4(a).

  • Project Milestones means the project milestones set forth in Schedule-G;

  • Milestone Failure means a failure by the Grant Recipient fully to achieve any Milestone by the relevant Milestone Date;

  • EBITDA Target means the Company's projected earnings before interest, taxes, one-time transition expenses, non-cash compensation expense charges, depreciation and amortization, as contained in the Company's budget for the Applicable Period and which is approved by the Board (without reference to any adjustments or revision, upwards or downwards, to such projected earnings which are subsequently approved by the Board as part of any subsequent revision to such budget), and (ii) the term "Financial Results" shall mean the Company's EBITDA calculated by reference to the Company's financial statements for the Applicable Period as filed with the Securities and Exchange Commission (the "SEC").

  • KPI Target means the acceptable performance level for a KPI as set out in each KPI;

  • Phase I Clinical Study means, as to a particular Licensed Product, an initial clinical study in humans with the purpose of assessing the Licensed Product’s safety, tolerability, toxicity, pharmacokinetics or other pharmacological properties.

  • Phase II Clinical Study means a human clinical study of a product initiated to determine the safety and efficacy in the target patient population, as described 21 C.F.R. 312.21(b).

  • Phase III Clinical Study means a trial involving administration of a Compound to sufficient numbers of human patients with the goal of establishing that the Compound is safe and efficacious for its intended use, to define warnings, precautions and adverse reactions that are associated with the drug or label expansion of such Compound, and to be considered as a pivotal study for submission of an NDA.

  • Phase IIb Clinical Trial means a clinical trial of a Product on sufficient numbers of patients that is designed to provide a preliminary determination of safety and efficacy of such Product in the target patient population over a range of doses and dose regimens.

  • Third Target Distribution means $0.5250 per Unit per Quarter (or, with respect to the period commencing on the Closing Date and ending on September 30, 2005, it means the product of $0.5250 multiplied by a fraction of which the numerator is equal to the number of days in such period and of which the denominator is 92), subject to adjustment in accordance with Section 6.6 and Section 6.9.